Home / Centerstage / 2026 / april / Week 2 /
US president signs an executive order easing research restrictions on psychedelic drugs such as "magic mushrooms" to accelerate studies on mental health treatments. The move aims to reduce bureaucratic hurdles, improve data sharing between the Food and Drug Administration and the Department of Veterans Affairs, and enable faster rescheduling if medical benefits are proven. While the order facilitates research, it does not immediately legalize therapeutic use, as these substances remain classified as high-risk and require formal approval before broader clinical application.
Sunday, 19 April, 2026